Turquoise Health Closes $40 Million Series C Round Led by Oak HC/FT
  • News
  • North America

Turquoise Health Closes $40 Million Series C Round Led by Oak HC/FT

The round will help expand its platform for transparent healthcare pricing and payment transactions.

3/18/2026
Ghita Khalfaoui
Back to News

Turquoise Health, a platform dedicated to reforming healthcare's financial infrastructure, has successfully raised $40 million in a Series C funding round. The investment was led by Oak HC/FT, with significant participation from existing investors including Andreessen Horowitz, Adams Street Partners, and Yosemite. This new capital injection will be used to accelerate product development, expand go-to-market efforts, and solidify the company's role in creating a more transparent payment system.


Tackling Healthcare's Financial Complexity

The American healthcare industry is burdened by a broken financial system, contributing to nearly $1 trillion in annual administrative waste. A core issue is that contracts governing payments are stored in disparate systems, inconsistently interpreted, and largely invisible to the parties involved. This structural problem leads to payment inaccuracies, claim denials, and a confusing financial experience for patients often culminating in surprise bills.

An Operating System for Healthcare Payments

Turquoise Health addresses these challenges with a multi-sided platform designed to create a new standard for pricing, contracting, and transacting. Its "Clear Rates" feature synthesizes machine-readable files, claims data, and Medicare benchmarks into a single, auditable rate for every payer-provider combination. This establishes a clear and actionable source of truth, moving away from the industry's historical pricing opacity.

The platform’s "Contracts" feature utilizes artificial intelligence to transform static legal documents into a dynamic operating system for healthcare finance. This innovation allows teams to instantly find contract details, compare performance across agreements, and model complex negotiation scenarios in just a few clicks. The ultimate goal is to create a foundation where transparent, same-day transactions become the industry norm.

Woven throughout the platform is "AskTQ," an AI-powered layer that reduces manual research time from weeks to mere seconds. Co-founder and CEO Chris Severn stated that the company is evolving from a data vendor to a full workflow and transaction platform. This strategic shift is intended to build the necessary infrastructure for transparent, real-time payments to become the industry standard.

Strong Growth and Investor Validation

The company has demonstrated significant market momentum, expanding its customer base to over 280 organizations since its founding five years ago. Its clients include 10 of the top 25 health systems, four of the five national payers, and nine of the top 10 pharmaceutical companies. This widespread adoption underscores a clear industry demand for greater financial clarity and operational efficiency.

Investor confidence is high, reflecting the platform's unique market position and proven impact. Vig Chandramouli, a Partner at Oak HC/FT, highlighted Turquoise Health's central role in the healthcare economy and its ability to expand adoption across providers, payers, and employers. He praised the platform for embedding transparency directly into the negotiation and payment workflows of the industry's largest stakeholders.


This latest funding round positions Turquoise Health to significantly advance its mission of demystifying healthcare costs for all parties. By building the essential infrastructure for transparent pricing and streamlined payments, the company is poised to reduce administrative burdens across the board. Ultimately, these efforts are paving the way for a more efficient, predictable, and equitable healthcare system.